期刊文献+

DARPP-32磷酸化参与天芪平颤颗粒缓解帕金森病运动并发症的发生 被引量:3

Phosphorylated DARPP-32 involved in the remission of levodopa-induced dyskinesia by Tianqi anti-tremor granules in Parkinson's disease
下载PDF
导出
摘要 目的研究天芪平颤颗粒对帕金森病(PD)运动并发症大鼠异常不自主行为学及纹状体DARPP-32(Thr75)磷酸化表达的影响,探讨长期左旋多巴使用后天芪平颤颗粒对异动症(LID)的作用机制。方法 6-羟基多巴胺(6-OHDA)制备PD大鼠模型并给予左旋多巴治疗4周,制备LID大鼠模型,将LID大鼠随机分为5组,分别给予大鼠生理盐水(LID模型组)、左旋多巴(西药组)以及小、中、大剂量天芪平颤颗粒组,另设假手术组(n=5)为对照组,并用免疫组化和Western blotting法观察各组大鼠纹状体内磷酸化DARPP-32(Thr75)的表达情况。结果长期使用左旋多巴后,PD大鼠出现刻板运动和进行性增加的对侧旋转等行为学改变。天芪平颤颗粒可明显缓解LID大鼠的不自主运动行为。免疫组化结果显示,西药组磷酸化DARPP-32(THr75)表达较LID模型组降低〔(3.53±0.20)×104 vs.(3.85±0.30)×104,P<0.05〕,大、中、小剂量中药组磷酸化DARPP-32(THr75)表达量分别为(8.54±0.17)×104、(8.10±0.31)×104、(7.06±0.69)×104,较西药组升高(P<0.05)。Western blotting结果与免疫组化基本一致,西药组磷酸化DARPP-32(THr75)灰度值与LID模型组比较无统计学差异〔(0.97±0.24)×106 vs.(1.08±0.12)×106,P>0.05〕,大、中、小剂量中药组大鼠纹状体磷酸化DARPP-32(THr75)灰度值分别为(2.40±0.09)×106、(2.37±0.16)×106、(1.44±0.14)×106,较西药组升高(P<0.05)。结论天芪平颤颗粒可降低LID大鼠的异常不自主运动评分,其机制可能是通过逆转磷酸化DARPP-32(THr75)表达的进一步下降,从而抑制了PKA通路的过度活化;DARPP-32磷酸化参与了治疗PD运动并发症的机制。 Objective To study effects of Tianqi anti-tremor granules on behavior and expression of phosphorylated DARPP-32(Thr75)in striatum of Parkinsonian rats with abnormal involuntary movements(AIM),and to explore the effects of Tianqi anti-tremor granules on mechanism of levodopa-induced dyskinesia.Methods Six unilateral hydroxydopamine-lesioned rat,the model of Parkinson disease(PD),were treated with 1evodopa/benserazide twice daily for 4 weeks in order to construct the model of LID.In contiguous 4 weeks,LID rats were randomly divided into 5 groups and treated with saline,levodopa,traditional Chinese medicine(TCM)-low,TCM-medium,and TCM-high,respectively.Other 5 rats with sham-operation were served as controls.Rats were then sacrificed,and immunohistochemical and Western blotting techniques were used to measure the expression of phosphorylated DARPP-32(Thr75)in striatum.Results Pulsatile treatment with levodopa gradually induced AIM,including stereotypy(limb dyskinesia,axial dystonia and masticatory dyskinesia)towards the side contralateral to the dopamine-denervated striatum,and increased contralateral rotation.Treatment with Tianqi anti-tremor granules can relieve AIMs of LID rats apparently.Immunohistochemical study showed that the expression of phosphorylated DARPP-32(Thr75)in striatum of levodopa group diminished to(3.53±0.20)×10^4(P〈0.05),while it was increased to(8.54±0.17)×10^4,(8.10±0.31)×10^4,(7.06±0.69)×10^4(P〈0.05,respectively)in the 3 groups treated with Levodopa plus 3 doses of Tianqi anti-tremor granules.Western blotting showed that the gray value of phosphorylated DARPP-32(Thr75)was decreased in the levodopa group(0.97±0.24)×10^6(P〉0.05),while it was increased to(2.40±0.09)×10^6,(2.37±0.16)×10^6,(1.44±0.14)×10^6,respectively,in the high,medium and low dose groups(P〈0.05).Conclusions Tianqi anti-tremor granules can decrease AIM scores of LID rats,inhibit the overactive of PKA pathway through reversing the decreased expression of phosphorylated DARPP-32(Thr75);DARPP-32 takes part in healing levodopa-induced dyskinesia.
出处 《中国神经免疫学和神经病学杂志》 CAS 北大核心 2012年第5期332-336,341,共6页 Chinese Journal of Neuroimmunology and Neurology
基金 国家自然科学基金(81071025 81171203 81171204) 上海市科技委员会项目(11nm0503300 11410708900 12XD1403800) 上海市教育委员会项目(10ZZ72)
关键词 帕金森病 异动症 左旋多巴 DARPP-32 天芪平颤颗粒 Parkinson' s diseasel dyskinesia levodopa DARPP-32 Tianqi anti-tremor granules
  • 相关文献

参考文献10

  • 1Thanvi B, Lo N, Robinson T .Levodopa-induced dyskinesia in Parkinson's disease: clinical features, pathogenesis, prevention and treatment[J].Postgrad Med J, 2007,83 (980):384-388.
  • 2刘振国,戚辰.帕金森病运动并发症及其治疗策略[J].中华医学杂志,2009,89(35):2516-2519. 被引量:11
  • 3宋璐,马雅萍,刘振国,巴茂文,卞雷斯.左旋多巴诱导帕金森病异动症与纹状体DARPP-32磷酸化的关系[J].中国神经免疫学和神经病学杂志,2011,18(1):1-4. 被引量:9
  • 4Deogaonka M, Subramanian T. Pathophysiological basis of drug-induced dyskinesia in Parkinson' s disease [J]. Brain Res, 2005, 50: 156-158.
  • 5Cerasa A, Messina D, Pugliese P,et al. Increased prefrontal volume in PD with levodopa-induced dyskinesias: A voxel-based morphometry study[J]. Mov Disord, 2011,3 : 1-6.
  • 6南京中医药大学编著.中药大辞典[M].上海科学技术出版社,2005,138,3367
  • 7Wang X, Liang XB, Li FQ, et al. Therapeutic strategies for Parkinson's disease: The ancient meets the ruture-traditional chinese herbal medicine, electroacupuncture, gene therapy and stem cells[J]. Neurochem Res, 2008, 33:1956-1963.
  • 8Rosenegger D, Lukowiak K. The participation of NMDA receptors, PKC, and MAPK in the formation of memory following operant conditioning in Lymnaea[J]. Mol Brain,2010, 3:24.
  • 9Santini E, Valjent E, Usiello A, et al. Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia[J]. J Neurosei, 2007,27: 6995-7005.
  • 10Aubert I, Guigoni C, Hakansson K, et al. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia[J]. Ann Neurol, 2005, 57(1):17-26.

二级参考文献24

  • 1巴茂文,刘振国.左旋多巴诱发异动症的病理生理机制研究进展[J].中华神经科杂志,2005,38(6):403-404. 被引量:23
  • 2巴茂文,刘振国,孔敏,马国诏,陈生弟,陆国强.5-羟色胺1A受体激动剂8-OH-DPAT改善帕金森病运动并发症的实验研究[J].中华神经科杂志,2007,40(2):80-83. 被引量:4
  • 3Marsden CD, Fahn S. Movement disorders. London: Butterworth, 1982 : 96-122.
  • 4Hardie R J, Lees AJ, Stern GM. On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study. Braln,1984, 107 ( Pt 2 ) :487-506.
  • 5Van Gerpen JA, Kumar N, Bower JH, et al. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol, 2006, 63: 205- 209.
  • 6Ahlskog JE, Muenter MD. Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord, 2001,16:448-458.
  • 7Fahn S, Oakes D, Shoulson I, et al. Levodopa and the progression of Parkinson' s disease. N Engl J Med, 2004,351 : 2498 -2508.
  • 8Hagell P, Piccini P, Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci,2002, 5:627-628.
  • 9Freed CR, Greene PE, Breeze RE, et al. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med, 2001,344:710-719.
  • 10de la Fuente-Feruondez R, Sehulzer M, Mak E, et al. Presynaptic mechanisms of motor fluctuations in Parkinson' s disease: a probabilistic model. Brain,2004,127(Pt 4) :888-899.

共引文献18

同被引文献26

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部